Newly elected city councillors Reed Clarke and Mike Elliott are leaving the Better Edmonton party to sit as independents.
CABOMETYX has emerged as a leader in the treatment of second-line plus neuroendocrine tumors, capturing over 40% of the new patient share for oral therapies. This success highlights Exelixis’ ability ...